I am a
Home I AM A Search Login

Papers of the Week


Papers: 17 Feb 2024 - 23 Feb 2024


2024 Feb 21


N Engl J Med


38381664

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.

Authors

Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA

Abstract

Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator-activated receptor delta agonist, has potential benefits.